A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsAlberto Zori Comba, A. Schmilovich, R. Giglio et al.|European Journal of Cancer|2001Cited by 37
In spite of enhancing the complete response (CR) rate with more cycles of neoadjuvant chemotherapy (NACT) only an early complete response (ECR) correlates with a better disease free survival (DFS) for larynx preservation (LP)R. Giglio, Pablo Menéndez, R Pradier et al.|Journal of Clinical Oncology|2004Cited by 0
Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT)Berta Roth, Marcelo Bonomi, R. Giglio et al.|Journal of Clinical Oncology|2004Cited by 0
In spite of enhancing the complete response (CR) rate with more cycles of neoadjuvant chemotherapy (NACT) only an early complete response (ECR) correlates with a better disease free survival (DFS) for larynx preservation (LP)R. Giglio, Pablo Menéndez, R Pradier et al.|Journal of Clinical Oncology|2004Cited by 0